Has Arthur Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $617 in general payments to Arthur Smith, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arthur Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arthur Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arthur Smith, MD

Neurological Surgery · Piedmont, SCNPI 1629000856

Payments from drug & device makers

$617in general payments, 2019–2025

Across 23 payments — averaging $26.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$347
AbbVie$114
Novartis$38
Sunovion Pharmaceuticals Inc.$34
Lilly USA, LLC$32
E.r. Squibb & Sons, L.L.C.$30
plus $23 from 2 others

What the payments were for

Travel & lodging$21835%
Food & beverage$36960%
Education$305%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	7	$347
AbbVie(2 entities)	6	$114
Novartis	2	$38
Sunovion Pharmaceuticals Inc.	2	$34
Lilly USA, LLC	2	$32
E.r. Squibb & Sons, L.L.C.	2	$30
Bristol Myers Squibb	1	$12
Supernus Pharmaceuticals, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VNS Therapy$218

How this compares

$617 in reported general payments places this provider in the 20th percentile of 114 neurological surgery providers in South Carolina.

See all neurological surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$35,554

Medicare patients

Services billed

298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BriviactBrivaracetam	13	$18,323
QuliptaAtogepant	14	$14,954
Dimethyl Fumarate	28	$4,336
Oxcarbazepine	89	$3,691
Levetiracetam	141	$3,028
TegretolCarbamazepine	12	$2,945
Lacosamide	50	$2,349
Carbamazepine ErCarbamazepine	23	$1,965
Gabapentin	162	$1,621
Phenobarbital	41	$1,518
Zonisamide	75	$1,442
Pregabalin	108	$1,247
Cyclobenzaprine Hcl	89	$834
Carbamazepine	30	$765
Eletriptan HbrEletriptan Hydrobromide	12	$726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieQulipta	$114	$14,95414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 114 neurological surgery providers in South Carolina.

Other neurological surgery in Piedmont

Alejandro SpiottaCharleston$1.6M
Jan Vargas MachajGreenville$656K
David JonesRock Hill$541K
Sabino DagostinoLadson$425K
Jonathan LenaCharleston$364K
Michael CowanRock Hill$184K
Kimberly KicielinskiCharleston$150K
Adam BackSpartanburg$100K
Charles OpalakGreenville$94K
Brett GunterWest Columbia$77K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →